ASU’s Biodesign Institute will utilize Piper Trust support to increase its capacity for automated, rapid diagnostic testing to mitigate the viral spread and potential reoccurrence of COVID-19.
“Now is the time for those who can — individuals and public- and private-sector organizations — to step in quickly and support our nonprofits,” said Mary Jane Rynd, president and CEO of Virginia G. Piper Charitable Trust. “They are serving on the frontlines and are essential to our economic vitality.”
Continue reading